CP and COVID-19: Based on the concept of passive immunization, human convalescent plasma (CP) from COVID‐19‐convalescent donors has emerged as an option for prevention and treatment of COVID‐19 considering that it can rapidly be made available and, theoretically, could be used for providing immediate immunity to susceptible individuals through viral neutralization [2].